跳至主要内容
临床试验/NL-OMON49641
NL-OMON49641已完成不适用

A Single-Center, Prospective Study in Healthy Volunteers for Validation of the O3 Regional Somatic Tissue Oxygenation Monitor - O3 validation study

MASIMO0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
MASIMO
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Age between 18 and 45 years
  • * Willing and able to provide written informed consent
  • * Healthy volunteer

排除标准

  • * Pregnant women (female subjects will have a pregnancy test prior to being
  • admitted to the study).
  • * Presence of any cardiovascular or pulmonary disease
  • * Exposure to high altitude(s) (>2000 m) within 30 days prior to the study
  • * Known allergy to intravenous contrast medium or heparin
  • * Volunteer has skin abnormalities affecting the digits such as psoriasis,
  • eczema, angioma, scar tissue, burn, fungal infection, substantial skin
  • breakdown, nail polish or acrylic nails that would prevent monitoring of SpO2
  • levels during the study
  • * Patients deemed not suitable for the study at the discretion of the
  • Investigator

研究者

发起方
MASIMO

相似试验